ARTICLE | Clinical News
MCB3837 regulatory update
August 15, 2016 7:00 AM UTC
FDA granted Qualified Infectious Disease Product (QIDP) and Fast Track designations to MCB3837 from Biovertis’ Morphochem AG subsidiary to treat Clostridium difficile infection (CDI). MCB3837 is a wa...